LabConnect Enhances Clinical Trial Support with A4P Acquisition

LabConnect has finalized the acquisition of A4P Consulting Ltd (A4P), a renowned scientific consultancy firm specializing in bioanalytical and biosample project management, and biomarker strategy. Headquartered in Discovery Park, Sandwich, Kent, U.K., with a subsidiary in Appenzell, Switzerland, A4P brings extensive expertise in regulated bioanalysis, genomics, personalized healthcare, and bespoke logistics solutions for pre-clinical and clinical trials.

The merger amplifies LabConnect's position as a global leader in central laboratory services and scientific-focused Functional Service Provider (FSP) Solutions. Through this collaboration, LabConnect aims to provide comprehensive support to pharmaceutical and biotechnology companies, contract research organizations (CROs), and NGOs in accelerating the development of new medicines worldwide. With a shared commitment to delivering tailored, timely, and flexible solutions, LabConnect and A4P offer an unparalleled breadth of technical and scientific proficiency to address the evolving demands of clinical research, ensuring efficient project management and compliance adherence from start-up to established global entities.

Read more